NM_014844.5:c.2939G>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014844.5(TECPR2):​c.2939G>C​(p.Arg980Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00248 in 1,613,744 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 16 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.84

Publications

5 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004566729).
BP6
Variant 14-102445811-G-C is Benign according to our data. Variant chr14-102445811-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECPR2NM_014844.5 linkc.2939G>C p.Arg980Thr missense_variant Exon 13 of 20 ENST00000359520.12 NP_055659.2
TECPR2NM_001172631.3 linkc.2939G>C p.Arg980Thr missense_variant Exon 13 of 17 NP_001166102.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECPR2ENST00000359520.12 linkc.2939G>C p.Arg980Thr missense_variant Exon 13 of 20 1 NM_014844.5 ENSP00000352510.7
TECPR2ENST00000558678.1 linkc.2939G>C p.Arg980Thr missense_variant Exon 13 of 17 1 ENSP00000453671.1
TECPR2ENST00000557786.1 linkn.548G>C non_coding_transcript_exon_variant Exon 4 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
471
AN:
152010
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000787
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.0271
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00212
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00348
AC:
874
AN:
251172
AF XY:
0.00345
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000725
Gnomad ASJ exome
AF:
0.00328
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0226
Gnomad NFE exome
AF:
0.00254
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00241
AC:
3526
AN:
1461616
Hom.:
16
Cov.:
30
AF XY:
0.00236
AC XY:
1717
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33468
American (AMR)
AF:
0.000850
AC:
38
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00272
AC:
71
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000835
AC:
72
AN:
86238
European-Finnish (FIN)
AF:
0.0216
AC:
1152
AN:
53414
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.00184
AC:
2045
AN:
1111842
Other (OTH)
AF:
0.00230
AC:
139
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
181
362
542
723
904
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00310
AC:
471
AN:
152128
Hom.:
3
Cov.:
31
AF XY:
0.00411
AC XY:
306
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41506
American (AMR)
AF:
0.000786
AC:
12
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4808
European-Finnish (FIN)
AF:
0.0271
AC:
287
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00212
AC:
144
AN:
68018
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00216
Hom.:
3
Bravo
AF:
0.00128
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00221
AC:
19
ExAC
AF:
0.00315
AC:
383
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00202
EpiControl
AF:
0.00190

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TECPR2: BP4, BS2 -

Hereditary spastic paraplegia 49 Benign:2
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Aug 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.0099
T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.29
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.87
D;D
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
1.8
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.028
Sift
Benign
0.61
T;T
Sift4G
Benign
0.12
T;T
Polyphen
0.42
B;.
Vest4
0.58
MVP
0.043
MPC
0.45
ClinPred
0.011
T
GERP RS
1.5
Varity_R
0.059
gMVP
0.41
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144147210; hg19: chr14-102912148; COSMIC: COSV63972002; COSMIC: COSV63972002; API